ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Silexion Therapeutics Corp
1.34
+0.0700
5.51%
盤後：
1.32
-0.0200
-1.49%
19:17 EDT
成交量：
21.68萬
成交額：
28.41萬
市值：
446.33萬
市盈率：
-0.15
高：
1.36
開：
1.26
低：
1.07
收：
1.27
52周最高：
22.36
52周最低：
1.07
股本：
333.08萬
流通股本：
299.54萬
量比：
6.42
換手率：
7.24%
股息：
- -
股息率：
- -
每股收益(TTM):
-8.9597
每股收益(LYR):
-395.3595
淨資產收益率：
-771.23%
總資產收益率：
-144.27%
市淨率：
1.71
市盈率(LYR):
0.00
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Silexion Therapeutics Corp
交易所：
NASDAQ
成立時間：
2008
員工人數：
13
公司地址：
The Goldyne Savad Inst. of Gene Therapy,Hadassah Hebrew Univ Medical Ctr,Jerusalem,Israel
官網：
http://www.silexion.com
郵編：
9112001
電話：
972 2 674 3430
傳真：
972 2 643 0982
簡介：
Silexion Therapeutics Corp是一家開曼群島豁免公司。Silexion Therapeutics Ltd.是Biomotion Sciences的子公司。Silexion Therapeutics Ltd.是一家臨床階段、專註於腫瘤學的生物技術公司，致力於發現和開發KRAS驅動的癌症的專有療法。Silexion的主要候選產品SIL-204B由局部給藥的小干擾RNA或siRNA組成，採用緩釋製劑，作為局部晚期胰腺癌患者的一線治療，與標準護理化療相結合。SIL-204B是繼Silexion的第一代siRNA候選產品SIG12D-LODER（也稱為Loder）的1期和2期臨床試驗之後的第二代siRNA候選產品。儘管未確定最大耐受劑量，但1期臨床試驗同時達到了主要和次要終點。在2期臨床試驗中，雖然沒有達到所有患者的主要終點，但結果显示KRAS G12D/V突變患者的治療組之間存在差異趨勢，Loder組的總體生存期優勢為9.3個月。關於2期臨床試驗中的次要安全性終點，達到了終點。對於次要療效終點，未觀察到統計學上的顯著差異，也沒有足夠的數據進行評估。由於1期和2期試驗的規模較小，它們沒有提供統計學意義。
董事
名稱
職位
Ilan Hadar
Chairman and Chief Executive Officer and Director
Amnon Peled
Director
Avner Lushi
Director
Dror J. Abramov
Director
Ilan Levin
Director
Ruth Alon
Director
Shlomo Noy
Director
股東
名稱
職位
Ilan Hadar
Chairman and Chief Executive Officer and Director
Mirit Horenshtein Hadar
Chief Financial Officer and Secretary
Mitchell Shirvan
Chief Scientific and Development Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SLXN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SLXN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","market":"US","secType":"STK","nameCN":"Silexion Therapeutics Corp","latestPrice":1.34,"timestamp":1774382400000,"preClose":1.27,"halted":0,"volume":216818,"hourTrading":{"tag":"盘后","latestPrice":1.32,"preClose":1.34,"latestTime":"19:17 EDT","volume":165,"amount":220.87,"timestamp":1774394242504,"change":-0.02,"changeRate":-0.014925,"amplitude":0.014925},"delay":0,"changeRate":0.05511811023622052,"floatShares":2995400,"shares":3330800,"eps":-8.959658,"marketStatus":"已收盤","change":0.07,"latestTime":"03-24 16:00:00 EDT","open":1.26,"high":1.355,"low":1.07,"amount":284096.842218,"amplitude":0.224409,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-8.959658,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":1.27,"preHourTrading":{"tag":"盘前","latestPrice":1.25,"preClose":1.27,"latestTime":"09:29 EDT","volume":44695,"amount":60001.7994485,"timestamp":1774358941017,"change":-0.02,"changeRate":-0.015748,"amplitude":0.204724},"postHourTrading":{"tag":"盘后","latestPrice":1.32,"preClose":1.34,"latestTime":"19:17 EDT","volume":165,"amount":220.87,"timestamp":1774394242504,"change":-0.02,"changeRate":-0.014925,"amplitude":0.014925},"volumeRatio":6.41629},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLXN\",,,,,undefined,":{"symbol":"SLXN","floatShares":2995400,"roa":"-144.27%","roe":"-771.23%","lyrEps":-395.359461,"volumeRatio":6.41629,"shares":3330800,"dividePrice":0,"high":1.355,"amplitude":0.224409,"preClose":1.27,"low":1.07,"week52Low":1.07,"pbRate":"1.71","week52High":22.36,"institutionHeld":0,"latestPrice":1.34,"eps":-8.959658,"divideRate":0,"volume":216818,"delay":0,"ttmEps":-8.959658,"open":1.26,"prevYearClose":1.92,"prevWeekClose":1.22,"prevMonthClose":1.725,"prevQuarterClose":1.92,"fiveDayClose":1.56,"twentyDayClose":1.5,"sixtyDayClose":2.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLXN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-29","symbol":"SLXN","defaultRemindTime":1753795800000,"type":"split","dateTimestamp":1753761600000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"US","date":"2024-11-29","symbol":"SLXN","defaultRemindTime":1732890600000,"type":"split","dateTimestamp":1732856400000,"forFactor":9,"toFactor":1,"ratio":9},{"market":"US","date":"2024-08-13","symbol":"SLXN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLXN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SLXN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1765857600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SLXN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SLXN","date":"2026-03-23","current":-0.149559,"percent":0.623894,"low":-1.070842,"twenty":-0.587662,"median":-0.432424,"eighty":-0.128686,"high":-0.075397,"avg":-0.418218,"sd":0.242466,"marketCap":3814503},"quantilePoints":[{"date":"2025-05-02","current":-0.511745,"twenty":-0.505522,"median":-0.478123,"eighty":-0.462658,"marketCap":8414615},{"date":"2025-05-09","current":-0.508623,"twenty":-0.511745,"median":-0.504017,"eighty":-0.475134,"marketCap":8363285},{"date":"2025-05-16","current":-0.49368,"twenty":-0.511295,"median":-0.503966,"eighty":-0.488849,"marketCap":8117579},{"date":"2025-05-23","current":-0.504427,"twenty":-0.509135,"median":-0.49826,"eighty":-0.470682,"marketCap":8294286},{"date":"2025-05-30","current":-0.491275,"twenty":-0.511407,"median":-0.49826,"eighty":-0.475032,"marketCap":8078030},{"date":"2025-06-06","current":-0.471573,"twenty":-0.511407,"median":-0.49368,"eighty":-0.475196,"marketCap":7754067},{"date":"2025-06-13","current":-0.453201,"twenty":-0.509647,"median":-0.491403,"eighty":-0.471409,"marketCap":7451983},{"date":"2025-06-20","current":-0.41963,"twenty":-0.506945,"median":-0.488844,"eighty":-0.464552,"marketCap":6899984},{"date":"2025-06-27","current":-0.415025,"twenty":-0.504283,"median":-0.484008,"eighty":-0.449824,"marketCap":6824252},{"date":"2025-07-03","current":-0.415025,"twenty":-0.504048,"median":-0.478123,"eighty":-0.41963,"marketCap":6824252},{"date":"2025-07-11","current":-0.42265,"twenty":-0.503966,"median":-0.474592,"eighty":-0.417174,"marketCap":6949630},{"date":"2025-07-18","current":-0.440049,"twenty":-0.503178,"median":-0.468758,"eighty":-0.415025,"marketCap":7235727},{"date":"2025-07-25","current":-0.430889,"twenty":-0.49932,"median":-0.464408,"eighty":-0.415332,"marketCap":7085105},{"date":"2025-08-01","current":-0.509697,"twenty":-0.49932,"median":-0.462719,"eighty":-0.415332,"marketCap":8380951},{"date":"2025-08-08","current":-0.292718,"twenty":-0.495931,"median":-0.452101,"eighty":-0.414513,"marketCap":4813156},{"date":"2025-08-15","current":-0.251096,"twenty":-0.493608,"median":-0.447572,"eighty":-0.409037,"marketCap":4128768},{"date":"2025-08-22","current":-0.231991,"twenty":-0.492964,"median":-0.436237,"eighty":-0.386752,"marketCap":3814623},{"date":"2025-08-29","current":-0.263889,"twenty":-0.49148,"median":-0.430786,"eighty":-0.303498,"marketCap":4339133},{"date":"2025-09-05","current":-0.238814,"twenty":-0.491275,"median":-0.423383,"eighty":-0.280777,"marketCap":3926818},{"date":"2025-09-12","current":-0.168193,"twenty":-0.491275,"median":-0.420859,"eighty":-0.25246,"marketCap":2765601},{"date":"2025-09-19","current":-0.12316,"twenty":-0.486413,"median":-0.417583,"eighty":-0.247343,"marketCap":2025116},{"date":"2025-09-26","current":-0.128618,"twenty":-0.486106,"median":-0.415793,"eighty":-0.244955,"marketCap":2114871},{"date":"2025-10-03","current":-0.128618,"twenty":-0.484008,"median":-0.415025,"eighty":-0.242737,"marketCap":2114871},{"date":"2025-10-10","current":-0.136465,"twenty":-0.48104,"median":-0.413413,"eighty":-0.231991,"marketCap":2243896},{"date":"2025-10-17","current":-0.121454,"twenty":-0.478123,"median":-0.409651,"eighty":-0.138853,"marketCap":1997067},{"date":"2025-10-24","current":-0.114972,"twenty":-0.478123,"median":-0.401489,"eighty":-0.132201,"marketCap":1890482},{"date":"2025-10-31","current":-0.112584,"twenty":-0.477611,"median":-0.386196,"eighty":-0.129301,"marketCap":1851214},{"date":"2025-11-07","current":-0.097914,"twenty":-0.471573,"median":-0.312505,"eighty":-0.127936,"marketCap":1609995},{"date":"2025-11-14","current":-0.097914,"twenty":-0.471163,"median":-0.292718,"eighty":-0.123842,"marketCap":1609995},{"date":"2025-11-21","current":-0.080173,"twenty":-0.468758,"median":-0.272333,"eighty":-0.121795,"marketCap":1318288},{"date":"2025-11-28","current":-0.096549,"twenty":-0.467039,"median":-0.257237,"eighty":-0.120362,"marketCap":1587556},{"date":"2025-12-05","current":-1.070842,"twenty":-0.471245,"median":-0.259284,"eighty":-0.119953,"marketCap":9902075},{"date":"2025-12-12","current":-1.0279,"twenty":-0.478706,"median":-0.282158,"eighty":-0.120362,"marketCap":9504991},{"date":"2025-12-19","current":-0.821644,"twenty":-0.486167,"median":-0.30227,"eighty":-0.120704,"marketCap":7597740},{"date":"2025-12-26","current":-0.797975,"twenty":-0.491377,"median":-0.316599,"eighty":-0.121181,"marketCap":7378875},{"date":"2026-01-02","current":-0.6492,"twenty":-0.495368,"median":-0.386196,"eighty":-0.12159,"marketCap":6003152},{"date":"2026-01-09","current":-0.710063,"twenty":-0.504027,"median":-0.401489,"eighty":-0.122205,"marketCap":6565948},{"date":"2026-01-16","current":-0.825025,"twenty":-0.510588,"median":-0.409651,"eighty":-0.122955,"marketCap":7629006},{"date":"2026-01-23","current":-0.726969,"twenty":-0.515839,"median":-0.412313,"eighty":-0.12316,"marketCap":6722280},{"date":"2026-01-30","current":-0.662725,"twenty":-0.574408,"median":-0.414769,"eighty":-0.123296,"marketCap":6128218},{"date":"2026-02-06","current":-0.510569,"twenty":-0.606596,"median":-0.415025,"eighty":-0.12391,"marketCap":4721229},{"date":"2026-02-13","current":-0.534237,"twenty":-0.597129,"median":-0.417327,"eighty":-0.124456,"marketCap":4940094},{"date":"2026-02-20","current":-0.534237,"twenty":-0.591719,"median":-0.41963,"eighty":-0.125548,"marketCap":4940094},{"date":"2026-02-27","current":-0.588338,"twenty":-0.588338,"median":-0.42265,"eighty":-0.127254,"marketCap":5440357},{"date":"2026-03-06","current":-0.557906,"twenty":-0.584956,"median":-0.42723,"eighty":-0.127936,"marketCap":5158959},{"date":"2026-03-13","current":-0.563418,"twenty":-0.591719,"median":-0.432424,"eighty":-0.128618,"marketCap":5209923},{"date":"2026-03-20","current":-0.377654,"twenty":-0.588338,"median":-0.436237,"eighty":-0.128618,"marketCap":4498612},{"date":"2026-03-23","current":-0.320224,"twenty":-0.587662,"median":-0.432424,"eighty":-0.128686,"marketCap":3814503}],"updateTime":1774395326057},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":134350646,"yearFounded":2008,"employeeNum":13,"address":"The Goldyne Savad Inst. of Gene Therapy,Hadassah Hebrew Univ Medical Ctr,Jerusalem,Israel","zipCode":"9112001","officePhone":"972 2 674 3430","officeFax":"972 2 643 0982"},"stockCompanyDetail":{"websiteUrl":"http://www.silexion.com","stockEarnings":[{"period":"1week","weight":-0.1911},{"period":"1month","weight":-0.1859},{"period":"3month","weight":-0.4752},{"period":"6month","weight":-0.6706},{"period":"1year","weight":-0.9257},{"period":"ytd","weight":-0.3385}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Silexion Therapeutics Corp是一家開曼群島豁免公司。Silexion Therapeutics Ltd.是Biomotion Sciences的子公司。Silexion Therapeutics Ltd.是一家臨床階段、專註於腫瘤學的生物技術公司，致力於發現和開發KRAS驅動的癌症的專有療法。Silexion的主要候選產品SIL-204B由局部給藥的小干擾RNA或siRNA組成，採用緩釋製劑，作為局部晚期胰腺癌患者的一線治療，與標準護理化療相結合。SIL-204B是繼Silexion的第一代siRNA候選產品SIG12D-LODER（也稱為Loder）的1期和2期臨床試驗之後的第二代siRNA候選產品。儘管未確定最大耐受劑量，但1期臨床試驗同時達到了主要和次要終點。在2期臨床試驗中，雖然沒有達到所有患者的主要終點，但結果显示KRAS G12D/V突變患者的治療組之間存在差異趨勢，Loder組的總體生存期優勢為9.3個月。關於2期臨床試驗中的次要安全性終點，達到了終點。對於次要療效終點，未觀察到統計學上的顯著差異，也沒有足夠的數據進行評估。由於1期和2期試驗的規模較小，它們沒有提供統計學意義。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.016335},{"month":2,"riseRate":0.6,"avgChangeRate":-0.095221},{"month":3,"riseRate":0.8,"avgChangeRate":-0.0418},{"month":4,"riseRate":0.75,"avgChangeRate":-0.019534},{"month":5,"riseRate":0.4,"avgChangeRate":0.010327},{"month":6,"riseRate":0.4,"avgChangeRate":-0.035519},{"month":7,"riseRate":1,"avgChangeRate":0.055675},{"month":8,"riseRate":0.4,"avgChangeRate":-0.277749},{"month":9,"riseRate":0.6,"avgChangeRate":-0.230878},{"month":10,"riseRate":0.4,"avgChangeRate":-0.091257},{"month":11,"riseRate":0.4,"avgChangeRate":-0.018649},{"month":12,"riseRate":0.2,"avgChangeRate":-0.12005}],"exchange":"NASDAQ","name":"Silexion Therapeutics Corp","nameEN":"Silexion Therapeutics Corp"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SLXN\",market:\"US\",,,undefined,":{"directors":[{"name":"Ilan Hadar","position":"Chairman and Chief Executive Officer and Director"},{"name":"Amnon Peled","position":"Director"},{"name":"Avner Lushi","position":"Director"},{"name":"Dror J. Abramov","position":"Director"},{"name":"Ilan Levin","position":"Director"},{"name":"Ruth Alon","position":"Director"},{"name":"Shlomo Noy","position":"Director"}],"executives":[{"name":"Ilan Hadar","position":"Chairman and Chief Executive Officer and Director"},{"name":"Mirit Horenshtein Hadar","position":"Chief Financial Officer and Secretary"},{"name":"Mitchell Shirvan","position":"Chief Scientific and Development Officer"}]}}}